Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3373 |  ACIU AC Immune SA - Common Stock | 2.55 USD | -0.78% | -10.21% | -6.59% | -27.14% | 259.44 M USD | ||
| 3383 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -0.93% | -8.97% | -11.98% | +32.30% | 255.22 M USD | ||
| 3387 |  STRO Sutro Biopharma, Inc. - Common Stock | 15.32 USD | +4.50% | -5.14% | -14.94% | -11.90% | 254.02 M USD | ||
| 3391 |  PALI Palisade Bio, Inc. - Common Stock | 1.45 USD | -2.03% | -0.68% | -29.27% | -14.71% | 252.69 M USD | ||
| 3420 |  IMRX Immuneering Corporation - Class A Common Stock | 3.74 USD | -3.11% | -8.78% | -17.44% | -40.35% | 241.97 M USD | ||
| 3450 |  EVMN Evommune, Inc. Common Stock | 6.40 USD | +2.89% | -10.86% | -39.05% | -63.05% | 232.27 M USD | ||
| 3454 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.82 USD | -7.14% | +8.98% | +62.50% | +100.00% | 231.60 M USD | ||
| 3459 |  KROS Keros Therapeutics, Inc. - common stock | 11.64 USD | +3.84% | +2.28% | +4.30% | -22.91% | 230.79 M USD | ||
| 3470 |  MGNX MacroGenics, Inc. - Common Stock | 3.55 USD | 0.00% | -2.47% | -12.99% | +100.56% | 226.14 M USD | ||
| 3471 |  ALEC Alector, Inc. - Common Stock | 2.02 USD | +5.21% | +5.76% | -9.01% | -36.08% | 225.55 M USD | ||
| 3481 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.14 USD | -1.62% | -14.22% | +4.13% | +33.86% | 222.23 M USD | ||
| 3484 |  SION Sionna Therapeutics, Inc. - Common Stock | 4.90 USD | +1.66% | -5.59% | -33.78% | -87.54% | 221.54 M USD | ||
| 3492 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.70 USD | -0.37% | -0.37% | +2.27% | -7.53% | 217.54 M USD | ||
| 3499 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 8.79 USD | +2.69% | -7.96% | -30.79% | -63.66% | 215.40 M USD | ||
| 3500 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 5.53 USD | -1.43% | +0.73% | -21.00% | -20.66% | 215.32 M USD | ||
| 3513 |  NAGE Niagen Bioscience, Inc. - Common Stock | 2.66 USD | -2.21% | -2.21% | -12.21% | -46.59% | 210.48 M USD | ||
| 3530 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.82 USD | +2.10% | -6.83% | -20.05% | -25.55% | 206.34 M USD | ||
| 3531 |  IVVD Invivyd, Inc. - Common Stock | 0.70 USD | -4.11% | -15.66% | -10.26% | -65.00% | 206.33 M USD | ||
| 3540 |  ADCT ADC Therapeutics SA Common Shares | 1.59 USD | +11.97% | +44.55% | +29.27% | -65.05% | 202.99 M USD | ||
| 3547 |  CGEN Compugen Ltd. - Ordinary Shares | 2.12 USD | -1.40% | -9.40% | -14.52% | +8.72% | 200.45 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |